Wolfrum, P.; Böhm, E.W.; König, S.; Lorenz, K.; Stoffelns, B.; Korb, C.A.
Safety and Long-Term Efficacy of Intravitreal rtPA, Bevacizumab and SF6 Injection in Patients with Submacular Hemorrhage Secondary to Age-Related Macular Degeneration. J. Clin. Med. 2025, 14, 3449.
https://doi.org/10.3390/jcm14103449
AMA Style
Wolfrum P, Böhm EW, König S, Lorenz K, Stoffelns B, Korb CA.
Safety and Long-Term Efficacy of Intravitreal rtPA, Bevacizumab and SF6 Injection in Patients with Submacular Hemorrhage Secondary to Age-Related Macular Degeneration. Journal of Clinical Medicine. 2025; 14(10):3449.
https://doi.org/10.3390/jcm14103449
Chicago/Turabian Style
Wolfrum, Peter, Elsa Wilma Böhm, Simon König, Katrin Lorenz, Bernhard Stoffelns, and Christina A. Korb.
2025. "Safety and Long-Term Efficacy of Intravitreal rtPA, Bevacizumab and SF6 Injection in Patients with Submacular Hemorrhage Secondary to Age-Related Macular Degeneration" Journal of Clinical Medicine 14, no. 10: 3449.
https://doi.org/10.3390/jcm14103449
APA Style
Wolfrum, P., Böhm, E. W., König, S., Lorenz, K., Stoffelns, B., & Korb, C. A.
(2025). Safety and Long-Term Efficacy of Intravitreal rtPA, Bevacizumab and SF6 Injection in Patients with Submacular Hemorrhage Secondary to Age-Related Macular Degeneration. Journal of Clinical Medicine, 14(10), 3449.
https://doi.org/10.3390/jcm14103449
